Evaluation of Heart Failure Telemonitoring Eligibility Criteria

Recruiting now

Conditions studied: Heart Failure

In brief

CARDIAUVERGNE is a heart failure telemonitoring system at Clermont-Ferrand's hospital. The aim of this study is to analyze the prognosis and evolution of patients after exclusion of telemonitoring. The patients were included from 1st January 2023 to 31st December 2024 and the monitoring was terminated for end of eligibility according to the French health authority criteria.

Key facts

Study ID

NCT07278583

Run by

University Hospital, Clermont-Ferrand

People needed

130

Starts

2025-12-05

Expected to finish

2026-12-01

Last updated by the study team

2026-07-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• adults
• able to read and understand french
• included in CARDIAUVERGNE telemonitoring program from 1st january 2023 to 31st december 2024 such as defined by the french health authorithy criteria (heart failure within 12 months or dyspnea at least NYHA 2 associated with NTproBNP of at least 1000pg/mL) and excluded by medical decision as no longer presenting eligibillity criteria

You may not qualify if…

• Patients leaving telemonitoring for other reasons (choice, death, medical reason, relocation, inobservance)

Where it is running

• CHU Clermont-Ferrand — Clermont-Ferrand, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.